PTC Therapeutics (PTCT) Short Interest Ratio & Short Volume → Elon to Transform U.S. Economy? (From Porter & Company) (Ad) Free PTCT Stock Alerts $40.12 +7.02 (+21.21%) (As of 05/20/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability PTC Therapeutics Short Interest DataCurrent Short Interest9,930,000 sharesPrevious Short Interest10,200,000 sharesChange Vs. Previous Month-2.65%Dollar Volume Sold Short$319.25 millionShort Interest Ratio11.1 Days to CoverLast Record DateApril 30, 2024Outstanding Shares76,700,000 sharesPercentage of Shares Shorted12.95%Today's Trading Volume2,858,311 sharesAverage Trading Volume969,499 sharesToday's Volume Vs. Average295% Short Selling PTC Therapeutics ? Sign up to receive the latest short interest report for PTC Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartPTCT Short Interest Over TimePTCT Days to Cover Over TimePTCT Percentage of Float Shorted Over Time Ad Stansberry ResearchWarren Buffett's "mystery stock"WARNING: Read This Before the Next Fed Meeting Investors are looking to the Fed with high hopes for interest rate relief. Unfortunately, many have no idea there's another major story unfolding right now, one that could be worth $40 trillion. This Wall Street millionaire just stepped forward with all the details, and how it could make some PTC Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/20249,930,000 shares $319.25 million -2.7%N/A11.1 $32.15 4/15/202410,200,000 shares $261.94 million -0.6%N/A11.4 $25.68 3/31/202410,260,000 shares $298.46 million -5.8%N/A10.8 $29.09 3/15/202410,890,000 shares $321.80 million -4.5%N/A10.9 $29.55 2/29/202411,400,000 shares $321.37 million +9.8%N/A10.5 $28.19 2/15/202410,380,000 shares $266.66 million -6.0%N/A9.7 $25.69 Get the Latest News and Ratings for PTCT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for PTC Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 1/31/202411,040,000 shares $288.03 million +10.7%N/A10.2 $26.09 1/15/20249,970,000 shares $272.48 million +1.9%N/A7.6 $27.33 12/31/20239,780,000 shares $269.54 million +6.1%N/A7.3 $27.56 12/15/20239,220,000 shares $261.76 million +3.7%N/A6.7 $28.39 11/30/20238,890,000 shares $204.65 million +10.0%N/A5.9 $23.02 11/15/20238,080,000 shares $167.82 million +9.5%N/A5.7 $20.77 10/31/20237,380,000 shares $138.38 million +5.1%N/A5.5 $18.75 10/15/20237,020,000 shares $143.14 million -12.4%N/A6 $20.39 9/30/20238,010,000 shares $179.50 million +8.5%N/A7.9 $22.41 9/15/20237,380,000 shares $193.80 million -0.3%N/A8.5 $26.26 8/31/20237,400,000 shares $292.30 million +2.6%N/A11.9 $39.50 8/15/20237,210,000 shares $297.48 million +2.3%N/A9.2 $41.26 7/31/20237,050,000 shares $284.40 million -5.5%N/A8.6 $40.34 7/15/20237,460,000 shares $292.28 million -3.2%N/A8.6 $39.18 6/30/20237,710,000 shares $313.57 million +2.7%N/A8.9 $40.67 6/15/20237,510,000 shares $326.61 million +18.5%N/A8.5 $43.49 5/31/20236,340,000 shares $266.09 million +16.8%N/A7.3 $41.97 5/15/20235,430,000 shares $300.28 million +4.0%N/A7 $55.30 4/30/20235,220,000 shares $287.83 million -0.4%N/A7.1 $55.14 4/15/20235,240,000 shares $258.17 million -2.4%N/A7.5 $49.27 3/31/20235,370,000 shares $260.12 million -1.5%N/A7.3 $48.44 3/15/20235,450,000 shares $254.73 million +9.0%N/A7.5 $46.74 2/28/20235,000,000 shares $218.35 million +0.4%N/A7.4 $43.67 2/15/20234,980,000 shares $229.78 million -14.1%N/A7.8 $46.14 1/31/20235,800,000 shares $266.16 million +22.6%N/A9.1 $45.89 1/15/20234,730,000 shares $226.00 million -8.7%N/A6.9 $47.78 12/30/20225,180,000 shares $197.72 million +11.4%N/A7.9 $38.17 12/15/20224,650,000 shares $179.03 million +3.3%N/A7.7 $38.50 11/30/20224,500,000 shares $186.71 million -5.1%N/A7.1 $41.49 11/15/20224,740,000 shares $180.36 million -1.5%N/A7.3 $38.05 10/31/20224,810,000 shares $181.91 million +1.9%6.9%7.5 $37.82 10/15/20224,720,000 shares $243.74 million -6.2%6.8%7.6 $51.64 9/30/20225,030,000 shares $252.51 million -7.7%7.2%8.8 $50.20 9/15/20225,450,000 shares $292.39 million +8.1%7.8%8.7 $53.65Exposed: 10 CENT Crypto to Explode May 20th? (Ad)Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 different coins that have returned over 100%... Today, he is now making the biggest crypto call of his ENTIRE career…Click For My #1 FREE Crypto for 2024 8/31/20225,040,000 shares $251.70 million -1.8%7.3%6.7 $49.94 8/15/20225,130,000 shares $271.48 million -1.0%7.4%6.6 $52.92 7/31/20225,180,000 shares $225.59 million -8.2%9.3%6.5 $43.55 7/15/20225,640,000 shares $247.14 million +11.9%10.2%7.3 $43.82 6/30/20225,040,000 shares $201.90 million -10.3%9.1%6.5 $40.06 6/15/20225,620,000 shares $147.19 million +3.3%10.1%7.3 $26.19 5/31/20225,440,000 shares $159.77 million +1.9%7.9%9 $29.37 5/15/20225,340,000 shares $168.96 million -11.7%7.7%9.2 $31.64 4/30/20226,050,000 shares $213.75 million +7.8%8.8%10.6 $35.33 4/15/20225,610,000 shares $249.65 million +4.5%8.1%9.9 $44.50 3/31/20225,370,000 shares $200.35 million -0.2%7.8%8 $37.31 3/15/20225,380,000 shares $184.10 million No Change7.8%7.7 $34.22 2/28/20225,380,000 shares $188.95 million +3.1%7.8%7.7 $35.12 2/15/20225,220,000 shares $215.12 million +5.7%7.6%6.9 $41.21 1/31/20224,940,000 shares $198.69 million -21.8%7.2%7 $40.22 1/15/20226,320,000 shares $276.50 million -7.9%9.2%9.3 $43.75 12/31/20216,860,000 shares $273.23 million -0.7%10.0%11.4 $39.83 12/15/20216,910,000 shares $262.65 million +16.7%10.1%13.6 $38.01 11/30/20215,920,000 shares $219.99 million -0.7%8.6%11.6 $37.16 11/15/20215,960,000 shares $231.49 million +10.8%8.7%12.7 $38.84 10/29/20215,380,000 shares $204.06 million +6.3%7.9%12 $37.93 10/15/20215,060,000 shares $192.74 million +7.7%7.4%11.3 $38.09 9/30/20214,700,000 shares $174.89 million +5.4%6.9%11.2 $37.21 9/15/20214,460,000 shares $180.90 million -0.9%6.5%10.7 $40.56 8/31/20214,500,000 shares $196.43 million -14.0%6.6%11.3 $43.65 8/13/20215,230,000 shares $209.25 million -1.9%7.7%12.9 $40.01 7/30/20215,330,000 shares $204.30 million +5.3%7.8%12.9 $38.33 7/15/20215,060,000 shares $217.48 million +4.8%7.4%10.2 $42.98 6/30/20214,830,000 shares $204.16 million +0.4%7.1%9.1 $42.27 6/15/20214,810,000 shares $210.73 million +1.1%7.1%8.8 $43.81 5/28/20214,760,000 shares $186.93 million -6.3%7.0%8.4 $39.27 5/14/20215,080,000 shares $195.02 million -2.7%N/A8.4 $38.39 4/30/20215,220,000 shares $221.85 million -0.8%N/A8.6 $42.50 4/15/20215,260,000 shares $251.95 million +0.8%N/A9.4 $47.90 3/31/20215,220,000 shares $244.30 million +2.2%N/A9.6 $46.80 3/15/20215,110,000 shares $298.68 million +7.1%N/A9.3 $58.45 2/26/20214,770,000 shares $263.26 million +19.0%N/A9 $55.19 2/12/20214,010,000 shares $253.73 million -2.0%N/A7.9 $63.28 1/29/20214,090,000 shares $230.55 million -2.6%N/A8.5 $56.37 1/15/20214,200,000 shares $288.62 million -11.0%N/A8.7 $68.72 12/31/20204,720,000 shares $288.30 million -3.9%N/A10.2 $61.08 12/15/20204,910,000 shares $324.11 million +5.4%N/A10.7 $66.01 11/30/20204,660,000 shares $298.19 million -0.6%N/A10 $63.99 11/15/20204,690,000 shares $281.87 million +4.0%N/A10.1 $60.10 10/30/20204,510,000 shares $243.04 million -9.6%N/A9.4 $53.89 10/15/20204,990,000 shares $261.23 million -3.5%N/A8.1 $52.35 9/30/20205,170,000 shares $241.70 million +4.2%N/A7.5 $46.75 9/15/20204,960,000 shares $236.05 million -13.0%N/A6.7 $47.59 8/31/20205,700,000 shares $281.69 million -9.4%N/A7.4 $49.42 8/14/20206,290,000 shares $308.34 million +22.4%N/A7.9 $49.02Elon to Transform U.S. Economy? (Ad)A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” grift of the elites. And yet, while it threatens their wealth and power, it could be transformational for both the U.S. economy and your wealth.One company holds a near-total monopoly on it. 7/31/20205,140,000 shares $238.14 million -6.0%N/A6.5 $46.33 7/15/20205,470,000 shares $297.90 million +4.2%N/A7.7 $54.46 6/30/20205,250,000 shares $265.86 million +7.4%N/A7.6 $50.64 6/15/20204,890,000 shares $240.73 million +11.1%N/A7 $49.23 5/29/20204,400,000 shares $223.12 million -1.4%N/A5.4 $50.71 5/15/20204,460,000 shares $217.78 million +10.7%N/A5.1 $48.83 4/30/20204,030,000 shares $205.21 million -7.4%N/A4.4 $50.92 4/15/20204,350,000 shares $206.10 million -3.3%N/A4.5 $47.38 3/31/20204,500,000 shares $238.77 million +11.5%N/A4.6 $53.06 3/13/20204,037,300 shares $183.41 million +8.0%N/A3.8 $45.43 2/28/20203,740,000 shares $152.55 million +7.5%N/A4.6 $40.79 2/14/20203,480,000 shares $178.70 million +0.9%N/A4.3 $51.35 1/31/20203,450,000 shares $187.47 million +3.0%N/A4.4 $54.34 1/15/20203,350,000 shares $188.07 million -4.0%N/A4.4 $56.14 12/31/20193,490,000 shares $181.20 million +10.1%N/A4.9 $51.92 PTCT Short Interest - Frequently Asked Questions What is PTC Therapeutics' current short interest? Short interest is the volume of PTC Therapeutics shares that have been sold short but have not yet been covered or closed out. As of April 30th, investors have sold 9,930,000 shares of PTCT short. Learn More on PTC Therapeutics' current short interest. What is a good short interest ratio for PTC Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. PTCT shares currently have a short interest ratio of 11.0. Learn More on PTC Therapeutics's short interest ratio. Is PTC Therapeutics' short interest increasing or decreasing? PTC Therapeutics saw a decline in short interest during the month of April. As of April 30th, there was short interest totaling 9,930,000 shares, a decline of 2.6% from the previous total of 10,200,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does PTC Therapeutics' short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to PTC Therapeutics: Indivior PLC (0.14%), ACADIA Pharmaceuticals Inc. (7.28%), Dyne Therapeutics, Inc. (18.91%), Rhythm Pharmaceuticals, Inc. (17.37%), Janux Therapeutics, Inc. (9.55%), Vera Therapeutics, Inc. (16.61%), Geron Co. (8.82%), MoonLake Immunotherapeutics (14.00%), Bausch Health Companies Inc. (5.73%), Arvinas, Inc. (12.66%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short PTC Therapeutics stock? Short selling PTCT is an investing strategy that aims to generate trading profit from PTC Therapeutics as its price is falling. PTCT shares are trading up $7.02 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against PTC Therapeutics? A short squeeze for PTC Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of PTCT, which in turn drives the price of the stock up even further. How often is PTC Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including PTCT, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: INDV Short Squeeze ACAD Short Squeeze DYN Short Squeeze RYTM Short Squeeze JANX Short Squeeze VERA Short Squeeze GERN Short Squeeze MLTX Short Squeeze BHC Short Squeeze ARVN Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:PTCT) was last updated on 5/21/2024 by MarketBeat.com Staff From Our PartnersExposed: 10 CENT Crypto to Explode May 20th?True Market Insiders[FREE Ticket] 27 Crypto Experts Reveal Their #1 Picks Crypto 101 Media**Breaking News** LIttle Known Biotech Company Does $41 Million In Q1! Huge AlertsHe Is Giving Away BitcoinCrypto Swap ProfitsBill Clinton Backing Biden Replacement???The Freeport SocietyConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe #1 Crypto for AIWeiss RatingsWarren Buffett's "mystery stock"Stansberry Research